dc.contributor.author | McGhee, David J M | |
dc.contributor.author | Royle, Pamela L | |
dc.contributor.author | Thompson, Paul A | |
dc.contributor.author | Wright, David E | |
dc.contributor.author | Zajicek, John P | |
dc.contributor.author | Counsell, Carl E | |
dc.date.accessioned | 2014-10-28T12:51:01Z | |
dc.date.available | 2014-10-28T12:51:01Z | |
dc.date.issued | 2013-04-12 | |
dc.identifier | 23850693 | |
dc.identifier | 8c54abc2-3add-4873-a24d-ab7de1b14b37 | |
dc.identifier | 23587062 | |
dc.identifier | 84877070118 | |
dc.identifier.citation | McGhee , D J M , Royle , P L , Thompson , P A , Wright , D E , Zajicek , J P & Counsell , C E 2013 , ' A systematic review of biomarkers for disease progression in Parkinson's disease ' , BMC Neurology , vol. 13 , 35 . https://doi.org/10.1186/1471-2377-13-35 | en |
dc.identifier.uri | http://hdl.handle.net/2164/3771 | |
dc.format.extent | 13 | |
dc.format.extent | 354894 | |
dc.language.iso | eng | |
dc.relation.ispartof | BMC Neurology | en |
dc.subject | Parkinson disease | en |
dc.subject | biomarkers | en |
dc.subject | disease progression | en |
dc.subject | clinical trials | en |
dc.subject | neuroprotective agents | en |
dc.subject | RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry | en |
dc.subject.lcc | RC0321 | en |
dc.title | A systematic review of biomarkers for disease progression in Parkinson's disease | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Chronic Disease Research Group | en |
dc.contributor.institution | University of Aberdeen.Grampian Data Safe Haven (DaSH) | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1186/1471-2377-13-35 | |